JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB144424

CAY10575, IKK-epsilon inhibitor

Be the first to review this product! Submit a review

|

(0 Publication)

MW 487.6 Da, Purity >95%. IKK-ε inhibitor (IC50 = 15.8 μM). Benzimidazole (ab143577) derivative.

View Alternative Names

Cell cycle regulated protein kinase, PLK, PLK1_HUMAN, Polo-like kinase 1, STPK 13, Serine/threonine-protein kinase 13, Serine/threonine-protein kinase PLK1

Key facts

CAS number

916985-21-2

Purity

>95%

Molecular weight

487.6 Da

Molecular formula

C<sub>2</sub><sub>2</sub>H<sub>2</sub><sub>1</sub>N<sub>3</sub>O<sub>6</sub>S<sub>2</sub>

PubChem

25190912

Nature

Synthetic

Solubility

Soluble in DMSO to 10 mM

Biochemical name

5-(5,6-dimethoxy-1H-benzimidazol-1-yl)-3-[[4-(methylsulfonyl)phenyl]methoxy]-2-thiophenecarboxamide

Biological description

IKK-ε inhibitor (IC50 = 15.8 μM). Benzimidazole (ab143577) derivative.

Canonical smiles

COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C(=O)N)OCC4=CC=C(C=C4)S(=O)(=O)C)OC

InChi

InChI=1S/C22H21N3O6S2/c1-29-17-8-15-16(9-18(17)30-2)25(12-24-15)20-10-19(21(32-20)22(23)26)31-11-13-4-6-14(7-5-13)33(3,27)28/h4-10,12H,11H2,1-3H3,(H2,23,26)

InChiKey

YYZTVTZCYVZGRB-UHFFFAOYSA-N

IUPAC Name

5-(5,6-dimethoxybenzimidazol-1-yl)-3-[(4-methylsulfonylphenyl)methoxy]thiophene-2-carboxamide

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com